Induction of Paclitaxel Resistance by ERα Mediated Prohibitin Mitochondrial-Nuclear Shuttling

Paclitaxel is a drug within one of the most promising classes of anticancer agents. Unfortunately, clinical success of this drug has been limited by the insurgence of cellular resistance. To address this, Paclitaxel resistance was modeled in an in vitro system using estrogen treated prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Pei, Jiang, Lijuan, Liu, Jianye, Wu, Zhiming, Guo, Shengjie, Zhang, Ziling, Zhou, Fangjian, Liu, Zhuowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871534/
https://www.ncbi.nlm.nih.gov/pubmed/24376711
http://dx.doi.org/10.1371/journal.pone.0083519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871534/
https://www.ncbi.nlm.nih.gov/pubmed/24376711
http://dx.doi.org/10.1371/journal.pone.0083519

Ejemplares similares